Arkolith/Insider Trading/AMLX/Form 4

Bedrosian Camille L

Chief Medical OfficerAmylyx Pharmaceuticals, Inc. (AMLX) · full profile →Form 4 · filed Dec 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$30K
Net Open-Market Flow
-$30K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 2, 2024Sell(S)5K$5.54$30K138K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-132885) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML